Raja Sangeetha, Mohapatra Satyajit, Kumar J S, Rani R Jamuna
Postgraduate Student, Department of Pharmacology, SRM Medical College Hospital and Research Centre , Potheri, Tamilnadu, India .
Assistant Professor, Department of Pharmacology, SRM Medical College Hospital and Research Centre , Potheri, Tamilnadu, India .
J Clin Diagn Res. 2014 Apr;8(4):HC01-3. doi: 10.7860/JCDR/2014/8010.4206. Epub 2014 Apr 15.
To evaluate the prescribing patterns of hypolipidaemic drugs which were prescribed to patients who visited the department of General Medicine in a tertiary care teaching hospital of southern India.
A cross-sectional study was done for three months in the department of General Medicine. A total of 506 prescriptions of hypolipidaemic drugs were evaluated, based on the various inclusion and exclusion criteria. The different disease patterns, the types of drugs which were prescribed in those diseases and the WHO prescription indicators, Anatomical Therapeutic Classification as well as the PDD (prescribing daily dose) /DDD (daily defined dose) ratio were calculated.
While analyzing the prescriptions, it was found that patients having abnormal lipid profiles (56.9%) and normal lipid profiles (43.1%) were prescribed hypolipidaemic drugs. Diabetes with hypertension (37%) was the most common disease for which hypolipidaemic drugs were prescribed. The average number of drugs per prescription was 3.3±1.33. Atorvastatin was the most common hypolipidaemic drug which was prescribed as monotherapy (53.4%), whereas atorvastatin with aspirin was the most common drug which was prescribed as combination therapy (20%). Atorvastatin was prescribed as underdosed and Rosuvastatin was prescribed as overdosed.
This study depicts the use of statins in various disease conditions, both as primary and secondary preventive measures. Such studies should be done to educate the physicians on good prescribing practices and on rational use of hypolipidaemic drugs.
评估印度南部一家三级护理教学医院普通内科门诊患者的降血脂药物处方模式。
在普通内科进行了为期三个月的横断面研究。根据各种纳入和排除标准,共评估了506份降血脂药物处方。计算了不同的疾病模式、这些疾病所开具的药物类型以及世界卫生组织处方指标、解剖治疗分类以及PDD(规定日剂量)/DDD(限定日剂量)比值。
在分析处方时发现,血脂异常患者(56.9%)和血脂正常患者(43.1%)都开具了降血脂药物。糖尿病合并高血压(37%)是开具降血脂药物最常见的疾病。每张处方的平均药物数量为3.3±1.33。阿托伐他汀是最常作为单一疗法开具的降血脂药物(53.4%),而阿托伐他汀与阿司匹林是最常作为联合疗法开具的药物(20%)。阿托伐他汀的处方剂量不足,瑞舒伐他汀的处方剂量过量。
本研究描述了他汀类药物在各种疾病状况下作为一级和二级预防措施的使用情况。应该开展此类研究,以教育医生养成良好的处方习惯并合理使用降血脂药物。